(no subject)
Dear Colleague,
Please find information about two upcoming courses arranged by the Swedish
Academy of Pharmaceutical Sciences.
Introduction to Quantitative Pharmacology and PK/PD for Drug Discovery &
Development Scientists, Munich, Germany, September 2-3, 2010
This course aims to give the delegates confidence and encouragement to have a
go at PKPD and to build relationships between bioscience, DMPK, medicinal
chemistry and related scientific disciplines. The programme is comprised of
lectures and afternoon group exercises.
Course objectives
* To raise awareness amongst bioscience, medicinal chemistry and clinical
scientists of what kinetic-dynamic (PKPD) methods can offer
* To raise awareness of the individual steps that makes up the
dose-plasma-distribution-binding-turnover- response process
* To raise awareness of experimental design. What investment has to be done
early and late in discovery?
* To build a case for the assessment of the first time in man dose
* To provide theory and methods of in vivo PKPD data
Who should attend?
Bioscience, safety, medicinal chemistry and clinical scientists, statisticians,
pharmacokineticists, pharmacologists etc.
Topics
* PK from a PD point of view
* PK half-life vs. half-life of response
* The apparent disconnection between PK and PD
* Emax-models and their difficulties if maximum response is lacking
* Effect compartment models in (distribution-rate limited) responses
* Turnover models in (turnover-rate limited) responses
* Receptor on/off binding models in (binding-rate limited) responses
* Scaling pharmacodynamics and PK properties to man
* Practical experimental design of PD studies
* PKPD assessment at milestone decisions
For further information, please visit our website:
www.lakemedelsakademin.se/munich
The 17th Intermediate Workshop on PK/PD Data Analysis: A Hands-on Course Using
WinNonlin, Rome, Italy, September 26-30, 2010
Course outline
Morning sessions consist of lectures dealing with choice of weights,
goodness-of-fit, interpretation of computer output, experimental design and
discrimination between rival models. Afternoon sessions are devoted to applying
the methods discussed in the lectures to actual data, using WinNonlin. One
afternoon session will be given as an introduction for participants with no, or
very little, experience with WinNonlin. The participants work on their own
laptops during the hands-on sessions.
Who should attend?
This workshop is intended for individuals engaged in the pharmaceutical
industry, regulatory agencies, contract research companies and universities and
for others who want to learn the aspects of model fitting. Previous
participants have been toxicologists, kineticists, bioanalytical chemists,
pharmacologists, clinical pharmacologists, anaesthesiologists, clinical
research assistants and scientists from academia and regulatory agencies.
Participants should have a background in pharmacokinetics but those with
limited experience would also benefit. The number of participants is limited.
Topics
*Introduction and overview
*Assessment of goodness of fit
*Pharmacodynamic issues
*Design of experiments
*Comparison of models
For further information, please visit: www.lakemedelsakademin.se/17th
With kind regards,
Annica Flodin, Projektadministratör/Project Administrator
Läkemedelsakademin
Box 1136, 111 81 Stockholm, Sweden
Besöksadress: Wallingatan 26A
Tel. 08-723 50 40; Fax 08-20 55 11
E-mail: [email protected]
<mailto:[email protected]>
Hemsida: www.lakemedelsakademin.se http://www.lakemedelsakademin.se/
<<image003.jpg>>